Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by greaterfoolFredon May 03, 2023 11:49am
55 Views
Post# 35427666

RE:RE:RNAi

RE:RE:RNAi
Boomskid wrote: I used to complain, ohhhh, about ten or twelve years ago, that if Bioasis didn't hurry up and do something that some other technology would come along and take a big bite out of Bioasis's cookie.

And yet, here we are, still noting every new thing that comes along that might take that bite, but nothing ever really has.

It's all still pretty much wide open.

If only...

jd




...if only XB3 could be shown to work in monkeys.

<< Previous
Bullboard Posts
Next >>